A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India
NCT06086353
·
clinicaltrials.gov ↗
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Transthyretin Amyloid Cardiomyopathy
Interventions
DRUG:
Tafamidis
Sponsor
Pfizer